vs
Side-by-side financial comparison of CENTURY ALUMINUM CO (CENX) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $633.7M, roughly 1.8× CENTURY ALUMINUM CO). CENTURY ALUMINUM CO runs the higher net margin — 0.3% vs -127.8%, a 128.1% gap on every dollar of revenue. On growth, CENTURY ALUMINUM CO posted the faster year-over-year revenue change (0.4% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $67.7M). Over the past eight quarters, CENTURY ALUMINUM CO's revenue compounded faster (13.8% CAGR vs 1.3%).
Century Aluminum Company is a US-based producer of primary aluminum, with aluminum plants in Kentucky, South Carolina and Iceland. It is the largest producer of primary aluminum in the United States. The company is a publicly held corporation listed on the NASDAQ. The headquarters is at One South Wacker in Chicago.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CENX vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $633.7M | $1.1B |
| Net Profit | $1.8M | $-1.4B |
| Gross Margin | 13.0% | 32.6% |
| Operating Margin | 5.2% | -116.0% |
| Net Margin | 0.3% | -127.8% |
| Revenue YoY | 0.4% | -2.5% |
| Net Profit YoY | -96.0% | -3093.9% |
| EPS (diluted) | $0.03 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $633.7M | $1.1B | ||
| Q3 25 | $632.2M | $1.0B | ||
| Q2 25 | $628.1M | $1.1B | ||
| Q1 25 | $633.9M | $1.0B | ||
| Q4 24 | $630.9M | $1.1B | ||
| Q3 24 | $539.1M | $1.1B | ||
| Q2 24 | $560.8M | $1.1B | ||
| Q1 24 | $489.5M | $1.1B |
| Q4 25 | $1.8M | $-1.4B | ||
| Q3 25 | $14.9M | $7.5M | ||
| Q2 25 | $-4.6M | $-8.4M | ||
| Q1 25 | $29.7M | $-6.4M | ||
| Q4 24 | $45.2M | $-44.4M | ||
| Q3 24 | $47.3M | $-21.0M | ||
| Q2 24 | $-2.5M | $-108.4M | ||
| Q1 24 | $246.8M | $2.0M |
| Q4 25 | 13.0% | 32.6% | ||
| Q3 25 | 12.2% | 36.1% | ||
| Q2 25 | 5.8% | 34.4% | ||
| Q1 25 | 9.6% | 37.6% | ||
| Q4 24 | 10.5% | 33.9% | ||
| Q3 24 | 15.2% | 37.2% | ||
| Q2 24 | 3.6% | 37.0% | ||
| Q1 24 | 3.4% | 33.1% |
| Q4 25 | 5.2% | -116.0% | ||
| Q3 25 | 9.2% | 7.0% | ||
| Q2 25 | 3.3% | 4.3% | ||
| Q1 25 | 7.3% | 4.5% | ||
| Q4 24 | 7.8% | 10.0% | ||
| Q3 24 | 11.8% | 7.4% | ||
| Q2 24 | 1.1% | -2.5% | ||
| Q1 24 | 0.4% | -5.1% |
| Q4 25 | 0.3% | -127.8% | ||
| Q3 25 | 2.4% | 0.7% | ||
| Q2 25 | -0.7% | -0.8% | ||
| Q1 25 | 4.7% | -0.6% | ||
| Q4 24 | 7.2% | -3.9% | ||
| Q3 24 | 8.8% | -1.9% | ||
| Q2 24 | -0.4% | -10.2% | ||
| Q1 24 | 50.4% | 0.2% |
| Q4 25 | $0.03 | $-10.23 | ||
| Q3 25 | $0.15 | $0.05 | ||
| Q2 25 | $-0.05 | $-0.06 | ||
| Q1 25 | $0.29 | $-0.05 | ||
| Q4 24 | $0.58 | $-0.32 | ||
| Q3 24 | $0.46 | $-0.15 | ||
| Q2 24 | $-0.03 | $-0.79 | ||
| Q1 24 | $2.26 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $134.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $805.6M | $2.9B |
| Total Assets | $2.3B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.2M | — | ||
| Q3 25 | $151.4M | $432.1M | ||
| Q2 25 | $40.7M | $454.2M | ||
| Q1 25 | $44.9M | $409.9M | ||
| Q4 24 | $32.9M | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $41.3M | $542.8M | ||
| Q1 24 | $93.5M | $658.5M |
| Q4 25 | $805.6M | $2.9B | ||
| Q3 25 | $741.8M | $4.4B | ||
| Q2 25 | $724.4M | $4.5B | ||
| Q1 25 | $726.3M | $4.4B | ||
| Q4 24 | $694.4M | $4.3B | ||
| Q3 24 | $628.5M | $4.6B | ||
| Q2 24 | $601.5M | $4.5B | ||
| Q1 24 | $601.5M | $4.7B |
| Q4 25 | $2.3B | $8.5B | ||
| Q3 25 | $2.1B | $10.1B | ||
| Q2 25 | $1.9B | $10.1B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $1.9B | $9.6B | ||
| Q3 24 | $2.1B | $11.2B | ||
| Q2 24 | $1.8B | $10.4B | ||
| Q1 24 | $1.8B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $102.8M | $175.4M |
| Free Cash FlowOCF − Capex | $67.7M | $148.6M |
| FCF MarginFCF / Revenue | 10.7% | 13.4% |
| Capex IntensityCapex / Revenue | 5.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 57.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $84.8M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $102.8M | $175.4M | ||
| Q3 25 | $2.0M | $51.7M | ||
| Q2 25 | $7.9M | $75.9M | ||
| Q1 25 | $72.3M | $-64.5M | ||
| Q4 24 | $-41.4M | $312.6M | ||
| Q3 24 | $20.1M | $42.2M | ||
| Q2 24 | $11.5M | $9.5M | ||
| Q1 24 | $-14.8M | $-1.4M |
| Q4 25 | $67.7M | $148.6M | ||
| Q3 25 | $-18.1M | $29.8M | ||
| Q2 25 | $-15.9M | $56.7M | ||
| Q1 25 | $51.1M | $-90.0M | ||
| Q4 24 | $-54.6M | $274.9M | ||
| Q3 24 | $-2.4M | $15.1M | ||
| Q2 24 | $-5.4M | $-18.9M | ||
| Q1 24 | $-44.5M | $-26.5M |
| Q4 25 | 10.7% | 13.4% | ||
| Q3 25 | -2.9% | 2.9% | ||
| Q2 25 | -2.5% | 5.4% | ||
| Q1 25 | 8.1% | -8.6% | ||
| Q4 24 | -8.7% | 24.2% | ||
| Q3 24 | -0.4% | 1.4% | ||
| Q2 24 | -1.0% | -1.8% | ||
| Q1 24 | -9.1% | -2.4% |
| Q4 25 | 5.5% | 2.4% | ||
| Q3 25 | 3.2% | 2.1% | ||
| Q2 25 | 3.8% | 1.8% | ||
| Q1 25 | 3.3% | 2.4% | ||
| Q4 24 | 2.1% | 3.3% | ||
| Q3 24 | 4.2% | 2.5% | ||
| Q2 24 | 3.0% | 2.7% | ||
| Q1 24 | 6.1% | 2.3% |
| Q4 25 | 57.11× | — | ||
| Q3 25 | 0.13× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | -0.92× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.06× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CENX
| Aluminum | $566.3M | 89% |
| Alumina | $67.4M | 11% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
